Companies › BIVI

BioVie Inc (BIVI)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001580149 · EDGAR filings · Updated 2026-07-17

BioVie Inc (BIVI) has reported institutional ownership of 13.7%, with 33 institutional managers holding positions valued at $1.44M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-17 — Registration statement (S-1) filed
• 2026-06-29 — EFFECT filed
• 2026-06-18 — Shelf registration (S-3) filed
• 2026-06-11 — DRS filed
• 2026-05-11 — Quarterly report (10-Q) filed
• 2026-03-25 — SCHEDULE 13D filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BioVie Inc has 33 institutional holders and institutional ownership of 13.7%.

Insider activity

Insiders reported 1 transactions (1 buys, 0 sells) across 1 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

Imunon Inc (IMNN) · PLUS THERAPEUTICS INC (PSTV) · Turn Therapeutics Inc (TTRX) · QUINCE THERAPEUTICS (QNCX) · AMERICAN SHARED HOSPITAL SVC (AMS) · MINK THERAPEUTICS INC (INKT)